Dr. Reddy's to Release Q3 FY12 Results on February 3, 2012

Earnings call slated for February 3, 6.30 PM IST / 8.00 AM EST

HYDERABAD, India--()--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter ended and Nine Months ended December 31, 2011 on Friday February 3, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.

Summary of Events

       
Event Date and Time (IST) Medium

Release of financial
results

February 3, after the Board Meeting

Email, Media, Company website,
Business Wire

Earnings Call February 3, 6.30 PM IST / 8:00 AM EST

Hosted by the Company
(Details below)

 

Webcast of Earnings
Call

February 3, 6.30 PM IST / 8:00 AM
EST through February 8, 2012

URL available on Company’s website,
www.drreddys.com

 

Transcripts of the
Earnings call

Will be available on the Company’s
website

URL available on Company’s website,
www.drreddys.com

 

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

 
Conference Dial-In Numbers
Primary Number:      

+91 22 6629 0356

Secondary Number:       +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:

6000 1221
Available in - Delhi, Bangalore, Chennai, Hyderabad, Kolkata
Accessible from all major carriers except BSNL/MTNL.
3940 3977

Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune,
Lucknow, Ahmedabad, Chandigarh

Accessible from all carriers.

International Toll Free Number:

USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448

 

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through February 8, 2012. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com

Contacts

Dr. Reddy’s Laboratories Ltd.
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Raghavender R, +91 40 49002135
raghavenderr@drreddys.com
or
Milan Kalawadia (USA), 1 9082034931
mkalawadia@drreddys.com

Sharing

Contacts

Dr. Reddy’s Laboratories Ltd.
Investor Relations:
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Raghavender R, +91 40 49002135
raghavenderr@drreddys.com
or
Milan Kalawadia (USA), 1 9082034931
mkalawadia@drreddys.com